Herantis Pharma Oyj
HRPMF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $635 | $5,503 | $5,036 | $5,630 |
| Short-Term Investments | $1,500 | $985 | $955 | $985 |
| Receivables | $406 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $257 | $241 | $118 |
| Total Curr. Assets | $2,571 | $6,746 | $6,232 | $6,758 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $160 |
| Long-Term Investments | $0 | $0 | $94,550 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $0 | $0 | $160 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2,571 | $6,746 | $6,232 | $6,918 |
| Liabilities | – | – | – | – |
| Payables | $278 | $749 | $660 | $788 |
| Short-Term Debt | $5 | $48 | $150 | $222 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $351 | $1,193 | $1,091 | $884 |
| Total Curr. Liab. | $634 | $1,989 | $1,902 | $1,895 |
| LT Debt | $25 | $30 | $4,391 | $4,469 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $2,155 | $0 | $0 | $0 |
| Total NC Liab. | $2,180 | $30 | $4,391 | $4,469 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $43 | $0 | $0 |
| Total Liabilities | $2,814 | $2,019 | $6,292 | $6,364 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $80 | $80 | $80 | $80 |
| Retained Earnings | -$80,069 | -$75,100 | -$75,380 | -$66,055 |
| AOCI | $0 | $79,746 | $75,239 | $66,530 |
| Other Equity | $79,746 | -$0 | $0 | -$0 |
| Total Equity | -$243 | $4,726 | -$60 | $554 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $2,571 | $6,746 | $6,232 | $6,918 |
| Net Debt | -$605 | -$5,426 | -$495 | -$939 |